Condition: Alcohol Use Disorder · Sponsor: VA Connecticut Healthcare System
The goal of the project is to evaluate whether donepezil + cognitive remediation therapy is superior to placebo in reducing heavy drinking in patients with alcohol use disorder in a double-blind, placebo-controlled trial.
This description comes directly from the study's public registry record.
Gihyun Yoon, MD · 203-932-5711 · gihyun.yoon@yale.edu
Always discuss trial participation with your own doctor first.
| VA Connecticut Healthcare System | West Haven, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05042102